Mandate

VINGE ADVISES DOMETIC IN RELATION TO ITS LISTING ON NASDAQ STOCKHOLM

November 25, 2015

Vinge advises Dometic Group AB (publ) in relation to its listing on Nasdaq Stockholm. A prospectus was published on 11 November 2015 and the first day of trading on Nasdaq Stockholm was 25 November 2015. The price in the offering was set at SEK 48 per share, corresponding to a market capitalisation of SEK 14,200 million for Dometic. The total value of the offering amounts to SEK 5,396 million, assuming that the over-allotment option is exercised in full.

Dometic provides branded solutions for mobile living in the areas of Climate, Hygiene & Sanitation and Food & Beverage. The Company manufactures and sells a broad range of products within these areas for use in recreational vehicles (such as motorhomes and caravans or towables), trucks and premium cars, pleasure and work boats, and for a variety of other uses. Products include air conditioners, furnaces, awnings, vents and windows & doors within Climate; water heaters and toilets within Hygiene & Sanitation; and refrigerators, cooking equipment, ovens and mobile coolers within Food & Beverage.

Vinge’s team primarily consisted of Jesper Schönbeck, Christina Kokko, Jo-Anna Nordström, David Andersson, Joakim Hagberg, Sabina Börjesson, Linda Sengul, Gustav Tengblad and Amanda Knutsson. Louise Brorsson Salomon and Adam Sandberg assisted in financing related matters, and Mattias Schömer, Tora Hansjons and Henrik Wastensson assisted in tax related matters.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025